Literature DB >> 9627027

The delta32 deletion of CCR5 receptor in rheumatoid arthritis.

S P Cooke1, G Forrest, P J Venables, A Hajeer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9627027     DOI： 10.1002/1529-0131(199806)41:6<1135::AID-ART24>3.0.CO;2-N

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  11 in total

1.  Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases.

Authors:  H Brühl; K Wagner; H Kellner; M Schattenkirchner; D Schlöndorff; M Mack
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.

Authors:  Caroline Desmetz; Yea-Lih Lin; Clément Mettling; Pierre Portalès; Herisoa Rabesandratana; Jacques Clot; Pierre Corbeau
Journal:  Immunology       Date:  2006-12       Impact factor: 7.397

3.  Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody.

Authors:  Pierre Portalès; Sylvie Fabre; Thierry Vincent; Caroline Desmetz; Brigitte Réant; Danièle Noël; Jacques Clot; Christian Jorgensen; Pierre Corbeau
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

4.  Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis.

Authors:  S Prahalad; J F Bohnsack; L B Jorde; A Whiting; B Clifford; D Dunn; R Weiss; M Moroldo; S D Thompson; D N Glass; M J Bamshad
Journal:  Genes Immun       Date:  2006-06-15       Impact factor: 2.676

5.  Association of the CCR5 gene with juvenile idiopathic arthritis.

Authors:  A Hinks; P Martin; E Flynn; S Eyre; J Packham; A Barton; J Worthington; W Thomson
Journal:  Genes Immun       Date:  2010-05-13       Impact factor: 2.676

6.  Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.

Authors:  S Prahalad
Journal:  Genes Immun       Date:  2006-04       Impact factor: 2.676

7.  CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis.

Authors:  Paul D Doodes; Yanxia Cao; Keith M Hamel; Yumei Wang; Rachel L Rodeghero; Tamas Kobezda; Alison Finnegan
Journal:  Arthritis Rheum       Date:  2009-10

Review 8.  Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica.

Authors:  M A Gonzalez-Gay
Journal:  Arthritis Res       Date:  2001-02-26

9.  CCR5 expression influences the progression of human breast cancer in a p53-dependent manner.

Authors:  Santos Mañes; Emilia Mira; Ramón Colomer; Sagrario Montero; Luis M Real; Concepción Gómez-Moutón; Sonia Jiménez-Baranda; Alfredo Garzón; Rosa Ana Lacalle; Keith Harshman; Agustín Ruíz; Carlos Martínez-A
Journal:  J Exp Med       Date:  2003-11-03       Impact factor: 14.307

10.  Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis.

Authors:  Ewald Lindner; Gry B N Nordang; Espen Melum; Berit Flatø; Anne Marit Selvaag; Erik Thorsby; Tore K Kvien; Oystein T Førre; Benedicte A Lie
Journal:  BMC Med Genet       Date:  2007-06-12       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.